Patient Safety & Systems-Based Practice

Value-based care and accountable care organizations

Clinical Overview and When to Suspect Value-Based Care Gaps

— Quality = process measures (HbA1c checked, mammogram done)

— Outcomes = HbA1c <8%, BP control, readmission rates

— Cost = total spend per attributed beneficiary per year

— Medicare Shared Savings Program (MSSP) is the largest ACO model under CMS

— If the ACO spends below a CMS benchmark while hitting quality targets → shares in savings

— If spends above benchmark (in two-sided risk tracks) → owes CMS money (downside risk)

— Stem mentions Medicare, ACO, MSSP, bundled payment, capitation, HEDIS, MIPS, MACRA, PCMH

— Vignette frames a decision between a costly low-value test and a guideline-concordant lower-cost option

— Question asks about population health, panel management, or care gaps (e.g., a registry shows 40% of diabetics overdue for retinal exam)

— Question pits individual patient autonomy against system-level cost containment

— MSSP ACO, ACO REACH (formerly Direct Contracting), Bundled Payments for Care Improvement (BPCI), Hospital Readmissions Reduction Program (HRRP), Hospital Value-Based Purchasing (VBP), MIPS (Merit-based Incentive Payment System).

Board pearl: ACOs differ from HMOs in that patients retain freedom to see any Medicare provider; attribution is retrospective based on plurality of primary care visits — patients are not "locked in," which is a frequent distractor.

Value-based care (VBC) ties physician/hospital payment to quality, outcomes, and total cost of care rather than volume of services delivered (fee-for-service, FFS).

Core equation: Value = (Quality + Outcomes + Patient Experience) ÷ Cost.

Accountable Care Organizations (ACOs) are groups of physicians, hospitals, and other providers who voluntarily accept shared responsibility for cost and quality of a defined Medicare patient panel.

When to "suspect" a value-based scenario on Step 3:

Key VBC programs to recognize:

Presentation Patterns and Key History

— A primary care physician in an MSSP ACO is reviewing a panel registry; the question asks which intervention will most improve quality scores AND reduce total cost.

— A patient is discharged after CHF admission; the question asks what reduces 30-day readmission (the HRRP-targeted condition).

— A clinic is transitioning to a Patient-Centered Medical Home (PCMH) model; what staffing or workflow change is most appropriate?

— A patient requests an MRI for uncomplicated low back pain; the question tests Choosing Wisely / low-value care avoidance.

— HRRP penalty conditions: AMI, CHF, COPD, pneumonia, CABG, elective hip/knee arthroplasty

— HEDIS/quality measures: diabetes (HbA1c, eye, foot, nephropathy), HTN control <140/90, colorectal/breast/cervical cancer screening, immunizations, depression screening (PHQ-9), tobacco cessation counseling

— Hospital-Acquired Conditions (HACs): CLABSI, CAUTI, C. difficile, pressure injuries, falls, surgical site infections — non-reimbursed under CMS rules

— "The clinic uses a patient registry…"

— "The ACO benchmark for…"

— "The patient has been seen by three specialists with overlapping medications…" (care coordination prompt)

— "Hospital is in the top quartile for readmissions…" (HRRP prompt)

Step 3 management: When the stem describes a fragmented care scenario (multiple specialists, duplicate imaging, polypharmacy), the highest-value answer is almost always care coordination through the primary care medical home — not another consult or repeat imaging. This is the single most tested VBC instinct on Step 3.

Step 3 vignettes rarely test ACO mechanics as trivia — they embed VBC reasoning into clinical decision-making, care transitions, and population management.

Classic stem archetypes:

Conditions repeatedly tied to VBC measures on Step 3:

"History" the question gives you that signals VBC framing:

Physical Exam Findings (Systems-Level "Exam" of a Practice or ACO)

— Is there an EHR-based patient registry for chronic disease tracking? (Required for PCMH recognition.)

— Are there standing orders/protocols for nurses (e.g., flu vaccines, foot exams)?

— Is there a care manager or care coordinator for high-risk patients?

— Does the clinic perform pre-visit planning and panel management?

— Run-rate reports: % of diabetics with HbA1c >9 (poorly controlled — a HEDIS measure)

— Risk stratification: identify the top 5% high-utilizer patients who drive ~50% of spend (Pareto principle in healthcare)

— Gaps-in-care lists: who is overdue for colonoscopy, mammography, A1c?

— Discharge-to-PCP follow-up rate within 7–14 days (CHF, COPD)

— Medication reconciliation completion at hospital discharge

— Specialist-to-PCP closed-loop referrals

— Benchmark vs. actual spending per attributed beneficiary

— Quality score relative to peer ACOs (CMS MSSP quality scoring)

— Readmission rate vs. expected (risk-adjusted)

— Per-member-per-month (PMPM) cost trend

Key distinction: A PCMH (Patient-Centered Medical Home) is a practice-level care delivery model emphasizing comprehensive, team-based, coordinated primary care — recognized by NCQA. An ACO is a payment-and-accountability structure spanning multiple practices/hospitals. A clinic can be a PCMH inside an ACO; the PCMH is the engine, the ACO is the chassis. Exam stems often conflate the two as a distractor.

In a VBC vignette there is no patient physical exam per se — instead, Step 3 tests your ability to "examine" a practice, panel, or health system and identify dysfunction.

Inspect the practice infrastructure:

Palpate the data:

Auscultate transitions:

Assess hemodynamics of the ACO:

Diagnostic Workup — Identifying Low-Value Care and Quality Gaps

— Imaging for acute low back pain <6 weeks without red flags

— DEXA in women <65 without risk factors

— Routine EKG/CXR in low-risk preoperative patients

— Antibiotics for viral URI, acute bronchitis, asymptomatic bacteriuria (non-pregnant, non-procedural)

— PSA screening without shared decision-making in men >70

— Continuous telemetry on low-risk non-cardiac admissions

— Routine vitamin D screening in asymptomatic adults

— Carotid imaging in syncope without focal neuro signs

— Colorectal cancer screening age 45–75

— Mammography age 40–74 q2y (2024 update)

— Cervical cancer screening (Pap/HPV per algorithm)

— Lung cancer LDCT age 50–80, ≥20 pack-yr, current/quit ≤15 yr

— AAA ultrasound men 65–75 ever-smokers (one-time)

— Statin for primary prevention if 10-yr ASCVD ≥10% + risk factor

— Hepatitis C screening all adults 18–79 once

— HIV screening 15–65 at least once

— Quality (process + outcome), Cost, Improvement Activities, Promoting Interoperability (EHR use)

Board pearl: When a stem offers both a guideline-recommended preventive service and a patient-requested low-value test, the correct VBC answer is to deliver the evidence-based service and decline the low-value test with patient education — never just acquiesce, and never refuse without explanation.

The "diagnostic workup" in VBC = identifying low-value services to eliminate and care gaps to close.

Choosing Wisely (ABIM Foundation) — high-yield examples to recognize as inappropriate on Step 3:

USPSTF Grade A/B services that ACOs must deliver (covered without cost-sharing under ACA):

Quality measure categories (CMS MIPS):

Diagnostic Workup — Advanced Population Health Analytics

— Risk stratification tools: Hierarchical Condition Category (HCC) coding, LACE index (Length of stay, Acuity, Comorbidity, ED visits) for readmission risk, Charlson Comorbidity Index

— Predictive modeling to flag patients likely to be admitted in next 6–12 months → enroll in care management

— Hot-spotting: geographic/utilization mapping of super-utilizers

— This is not upcoding when documentation supports it; it is clinical documentation integrity.

— Beneficiary is attributed to the ACO whose primary care clinicians delivered the plurality of primary care services in the performance year

— Patients can voluntarily align via Medicare.gov

— Historical spending of attributed beneficiaries, trended forward with national/regional growth rates

— Shared savings paid if actual < benchmark by minimum savings rate (MSR), typically 2–4%

— APM Performance Pathway (APP) measures: diabetes A1c control, BP control, screening for depression, falls screening, breast/colorectal cancer screening, patient experience (CAHPS)

Step 3 management: If a stem describes a Medicare patient with multiple chronic conditions seen primarily by a cardiologist who does her routine care, the patient may be attributed to the specialist if that cardiologist bills primary-care-equivalent E/M codes — a subtle point. Encouraging a clear primary care relationship is both better care and better attribution.

Population-level analytics ACOs and PCMHs use:

HCC risk adjustment: CMS pays ACOs more per attributed patient with higher documented comorbidity burden. Accurate, specific ICD-10 coding (e.g., "diabetes with diabetic nephropathy, stage 3 CKD" vs. "diabetes") raises the risk score and benchmark — making cost performance look better and reflecting true illness burden.

Attribution methodology (MSSP):

Benchmarking:

Quality scoring:

Risk Stratification and Tiered Care Management

— Tier 1 (70–80% of panel, low risk): healthy or well-controlled chronic disease → routine preventive care, patient portal outreach, group visits acceptable

— Tier 2 (15–20%, rising risk): 1–2 chronic conditions, moderate utilization → care coordinator check-ins, disease-specific education, structured chronic care visits

— Tier 3 (5%, high risk/high cost): multimorbidity, frequent admissions, polypharmacy, social complexity → intensive care management with embedded RN/social worker, home visits, transitional care management (TCM) post-discharge

— ≥2 hospitalizations or ≥4 ED visits in 12 months

— ≥10 chronic medications

— Recent major diagnosis (cancer, advanced heart failure, ESRD)

— Functional decline, frailty, lives alone

— Behavioral health + medical comorbidity (highest cost cohort)

— Food insecurity, housing instability, transportation, utilities, interpersonal safety, health literacy

— Z-codes (Z55–Z65) capture SDOH in EHR; CMS increasingly requires SDOH screening as a quality measure

— Collaborative Care Model (CoCM) — PCP + behavioral health care manager + consulting psychiatrist; reimbursable via CPT 99492-99494

— Improves PHQ-9 scores and is cost-saving

CCS pearl: When managing a complex outpatient with poorly controlled diabetes, depression, and recent admission, the highest-value CCS-style order set is: schedule PCP follow-up within 7 days, refer to care coordinator/care manager, initiate collaborative care for depression, perform medication reconciliation, screen SDOH. Avoid the reflex of "order more tests."

ACOs and PCMHs use a risk pyramid to deploy resources:

High-risk identification triggers:

Social Determinants of Health (SDOH) screening is now standard:

Behavioral health integration:

Pharmacotherapy — Medication Optimization in VBC

— Default to generic statins, ACEi/ARB, SSRIs, metformin

— Use formulary-preferred agents unless clinical reason documented

— Avoid brand-name combos when component generics suffice (e.g., separate ACEi + amlodipine vs. branded combo if cost is barrier — but consolidate pills for adherence when affordable)

— Proportion of Days Covered (PDC) ≥80% for statins, RAAS inhibitors, oral diabetes meds, DOACs

— 90-day fills and mail-order improve PDC

— Synchronize refills ("med sync")

— Beers Criteria, STOPP/START

— Eliminate PPIs without indication, benzodiazepines, anticholinergics, duplicate antihypertensives, sliding-scale-only insulin in long-term care

— SGLT2 inhibitors in T2DM with CKD, HFrEF, HFpEF, or ASCVD

— GLP-1 RAs in T2DM with ASCVD or obesity

— GDMT for HFrEF: ARNI + β-blocker + MRA + SGLT2i ("4 pillars")

— Statins when ASCVD ≥7.5–10%

— Antibiotics for viral illness, PPIs long-term without indication, sliding-scale insulin monotherapy, benzodiazepines for chronic insomnia

Board pearl: When a stem asks the single best intervention to reduce readmissions in HFrEF, the answer is initiation and titration of all 4 GDMT pillars with early (7-day) post-discharge follow-up and weight monitoring — not telemonitoring devices alone, which have mixed evidence.

Medication stewardship is a major lever for both quality and cost in ACOs.

Generic substitution and formulary alignment:

Adherence as a quality metric (Medicare Part D Star Ratings):

Deprescribing (key Step 3 concept, especially in elderly):

High-value pharmacotherapy upgrades that improve outcomes and reduce downstream cost:

Avoid low-value pharmacotherapy:

Procedures and Care-Delivery Interventions in VBC

— Phone contact within 2 business days of discharge

— Face-to-face visit within 7 days (high complexity, 99496) or 14 days (moderate, 99495)

— Medication reconciliation required

— Proven to reduce 30-day readmissions

— ≥2 chronic conditions expected to last ≥12 months

— ≥20 minutes/month of non-face-to-face care coordination

— Patient consent required (verbal documented or written)

— Health risk assessment, cognitive screening, fall risk, depression screening, advance care planning

— Not the same as a "physical exam" — high-yield distinction

— Reimbursable conversation about goals of care, POLST/MOLST, healthcare proxy

— Required quality measure in many ACO contracts

— BP cuffs for HTN, scales for HF, glucometers for DM

— Must transmit ≥16 days of data in a 30-day period

Step 3 management: Post-CHF discharge, the highest-yield bundle = TCM phone call within 48 hours + face-to-face visit within 7 days + med rec + enroll in CCM + initiate/up-titrate GDMT + daily weights with action plan. This sequence is the recurring "right answer" pattern.

"Procedures" in VBC = structured care-delivery interventions reimbursable under value-based codes.

Transitional Care Management (TCM) — CPT 99495/99496:

Chronic Care Management (CCM) — CPT 99490/99439/99487:

Principal Care Management (PCM) — for single high-risk condition

Annual Wellness Visit (AWV) — G0438/G0439:

Advance Care Planning (ACP) — CPT 99497/99498:

Remote Patient Monitoring (RPM) — CPT 99453/99454/99457:

Bundled payments (BPCI-A) for episodes (joint replacement, CABG, sepsis): single payment covers admission + 90 days post-discharge → incentivizes SNF stewardship and home health over institutional post-acute care.

Special Populations — Elderly and Renal/Hepatic Impairment

— Falls screening annually (CDC STEADI): ask about falls, gait/balance test (Timed Up & Go ≥12 sec abnormal), orthostatics, vision, footwear, home hazards, vitamin D if deficient

— Cognitive screening at AWV (Mini-Cog, MoCA)

— Polypharmacy review using Beers Criteria: avoid first-gen antihistamines, benzodiazepines, long-acting sulfonylureas (glyburide), muscle relaxants, anticholinergics

— Advance care planning — POLST when life expectancy <1 year or advanced illness

— Goals-of-care discussions before invasive interventions

— Frail patients benefit less from aggressive screening (e.g., stop screening colonoscopy when life expectancy <10 years, generally age ~75)

— De-intensify diabetes (A1c target 7.5–8.5%) and BP (SBP <150) in frail elderly per ADA/ACP

— Dose-adjust DOACs, gabapentin, metformin (avoid if eGFR <30), avoid NSAIDs

— Nephrology co-management at eGFR <30 (preserves transplant/dialysis access readiness — reduces emergent starts)

— SGLT2i now recommended down to eGFR ~20 for CKD/HFrEF

— Avoid acetaminophen >2 g/day in cirrhosis, avoid NSAIDs (variceal bleeding, HRS)

— Statin generally safe in stable chronic liver disease

Board pearl: The single highest-value geriatric intervention an ACO can deploy is comprehensive medication review and deprescribing — reduces falls, delirium, ED visits, and cost simultaneously, hitting multiple quality measures with one action.

Medicare beneficiaries (≥65 or disabled) are the core population of MSSP ACOs, making geriatric VBC the dominant Step 3 framing.

Geriatric-specific VBC priorities:

Frailty assessment (Clinical Frailty Scale, FRAIL scale) modifies decisions:

Renal impairment in VBC:

Hepatic impairment:

Special Populations — Pediatrics, Pregnancy, Dual-Eligibles, Underserved

— Pediatric quality measures: well-child visits per Bright Futures schedule, immunization rates (Combo 10), lead screening at 12 and 24 months, developmental screening, adolescent depression screening, BMI percentile documentation

— Asthma medication ratio (controller:total) ≥0.5 — high-yield HEDIS metric

— Prenatal/postpartum care visit completion

— Low primary cesarean rate (NTSV cesarean <23.6%) — Joint Commission perinatal core measure

— Postpartum depression screening (EPDS or PHQ-9) at 1–6 weeks

— Postpartum visit within 3 weeks (ACOG "fourth trimester")

— Long-acting reversible contraception (LARC) access reduces unintended pregnancy and cost

— Highest-cost, highest-complexity cohort (~20% of Medicare, ~35% of spend)

— Special Needs Plans (D-SNPs) coordinate benefits

— Heavy overlap with behavioral health, SDOH, LTSS needs

— CMS now requires ACOs to report stratified quality data by race, ethnicity, language, disability, SDOH

— ACO REACH model includes a mandatory Health Equity Plan and equity benchmark adjustment

— Implicit bias training, professional interpreters (not family members) for LEP patients, culturally tailored education

— FQHCs and RHCs participate via specific ACO pathways

— Telehealth parity post-PHE expanded access

Key distinction: Medicaid managed care uses capitation (PMPM payments to MCOs) — full prospective risk. MSSP ACOs retain FFS billing with retrospective shared-savings reconciliation. Both are "value-based," but the risk mechanics and patient experience differ — a classic distractor pair.

Pediatric ACOs and Medicaid managed care:

Pregnancy and perinatal VBC:

Dual-eligibles (Medicare + Medicaid):

Underserved and equity:

Rural populations:

Complications and Adverse Outcomes of VBC Models

— Selecting healthier patients to lower cost and improve metrics

— Avoiding complex/high-risk patients

— Mitigated by risk adjustment (HCC) and equity-adjusted benchmarks

— Documenting more severe diagnoses than supported to inflate HCC scores

— Fraudulent; subject to False Claims Act, DOJ enforcement

— Distinct from legitimate specificity in documentation

— Withholding needed services to cut cost

— Counter-balanced by quality measures (a denominator floor)

— Optimizing measured metrics while neglecting unmeasured care (e.g., obsessive A1c documentation while ignoring depression)

— Quality reporting fatigue, EHR clicks, prior authorization

— Contributes to clinician burnout (a patient safety issue)

— Aggressive A1c lowering in frail elderly → hypoglycemia, falls

— Aggressive BP lowering → syncope, AKI

— Statin/aspirin pushed beyond evidence in low-risk patients

— Reducing inpatient days may increase post-acute SNF use unless bundled

— 30-day readmission focus may delay legitimately needed readmissions to day 31

Board pearl: The classic Step 3 VBC trap is the frail 85-year-old whose A1c is 8.5% — a quality measure technically calls for tighter control, but the correct answer is to de-intensify therapy, accept the metric "miss," and document goals of care. Quality measures inform but do not override individualized care.

VBC, when poorly implemented, produces predictable harms — Step 3 expects you to recognize them.

Cherry-picking / lemon-dropping:

Upcoding:

Stinting / under-treatment:

Teaching to the test:

Administrative burden and burnout:

Patient-level harms:

Unintended cost-shifting:

When to Escalate — Consultation, Care Management, and System Triage

— Level 1: PCP visit, standard care

— Level 2: Care coordinator/RN care manager for chronic disease education and follow-up

— Level 3: Pharmacist consult (medication reconciliation, deprescribing, anticoagulation, diabetes titration)

— Level 4: Behavioral health integration (CoCM) for comorbid depression/anxiety/SUD

— Level 5: Social work for SDOH (housing, food, transportation, benefits navigation)

— Level 6: Specialist e-consult (asynchronous curbside) before formal referral

— Level 7: Formal specialist referral with closed-loop communication

— Level 8: Hospital-at-home or SNF-at-home programs (CMS Acute Hospital Care at Home waiver)

— Level 9: ED/inpatient admission

— Red flags overriding VBC frame: hemodynamic instability, sepsis, ACS, stroke, acute abdomen, suicidal ideation with plan, pregnancy complications, child abuse

— CKD stage 4+ → nephrology (preserves modality choice, reduces emergent dialysis starts)

— HFrEF NYHA III/IV → advanced HF clinic

— Uncontrolled DM with insulin → endocrinology + diabetes educator

— Persistent depression after 2 SSRIs → psychiatry via CoCM

Step 3 management: Always prefer e-consult or co-management over a single transactional referral when the question stem emphasizes fragmentation, cost, or medication errors across providers — these are coordination problems, not knowledge problems.

In VBC, "escalation" means deploying the right team member or resource at the right intensity, not always sending to a specialist or ED.

Stepwise escalation logic for a complex outpatient:

When to bypass and admit/refer urgently:

Specialist co-management (not just referral) for:

CCM/PCM enrollment for any patient with ≥2 chronic conditions expected to last ≥12 months — frequently the right Step 3 answer for "what next" in an ambulatory complex patient.

Key Differentials — Same-Category (Payment Model) Causes

— Payment per service; incentive = volume

— No accountability for outcomes or total cost

— Baseline against which all VBC is compared

— FFS plus bonus/penalty tied to quality metrics

— Limited downside, narrow scope

— Retrospective shared savings/losses vs. benchmark

— Tracks: Basic (one-sided then two-sided) and Enhanced (full two-sided risk)

— Patients retain freedom of choice; attribution retrospective

— Higher risk-sharing, prospective capitation options, mandatory health equity component

— Single episode payment (e.g., joint replacement + 90 days)

— Provider bears risk for post-acute spend

— Prospective PMPM payment; full insurance risk

— Network restrictions typical

— Private plans paid capitated rates with HCC risk adjustment + Star Ratings bonuses

— ~50% of Medicare beneficiaries

— Patient pays monthly retainer to PCP, often outside insurance

— Not technically VBC but aligned with longitudinal care incentives

— Individual clinician-level adjustment under MACRA

— Composite score across Quality, Cost, Improvement Activities, Promoting Interoperability

Key distinction: ACO ≠ HMO. ACOs are provider-led, retain patient choice, and use retrospective reconciliation. HMOs are insurer-led, restrict networks, and use prospective capitation. Mixing these up is the most common VBC question miss.

Distinguish VBC payment models — a recurring Step 3 distractor set.

Fee-for-service (FFS):

Pay-for-performance (P4P):

MSSP ACO (Medicare Shared Savings Program):

ACO REACH:

Bundled payments (BPCI-A, CJR):

Capitation (HMO, Medicare Advantage):

Medicare Advantage (Part C):

Direct primary care (DPC):

MIPS (Merit-based Incentive Payment System):

Key Differentials — Other-Category (Quality & Safety Frameworks) Causes

— IOM (NAM) Six Aims: Safe, Timely, Effective, Efficient, Equitable, Patient-centered (STEEEP)

— Triple Aim (IHI): better care, better health, lower cost → expanded to Quadruple Aim (+ clinician well-being) → Quintuple Aim (+ health equity)

— PDSA cycles (Plan-Do-Study-Act) for iterative practice change

— Lean / Six Sigma for waste reduction

— Root cause analysis (RCA) retrospectively for sentinel events

— Failure Mode and Effects Analysis (FMEA) prospectively for high-risk processes

— The Joint Commission — hospital accreditation, sentinel event review

— NCQA — PCMH recognition, HEDIS measure stewardship

— AHRQ — patient safety indicators, CAHPS surveys

— HRRP — readmission penalty (up to 3% Medicare payment reduction)

— HACRP — hospital-acquired condition penalty (1% reduction for worst quartile)

— VBP (Hospital Value-Based Purchasing) — 2% withhold redistributed by performance

— MACRA/QPP — physician payment reform (MIPS + Advanced APMs)

— HCAHPS (inpatient), CG-CAHPS (clinician/group), CAHPS for ACOs

— Patient-reported experience drives ~25% of hospital VBP score

Board pearl: When a stem asks about fixing a process (recurring medication errors at discharge), the answer is a PDSA cycle or systems redesign, not disciplinary action against an individual — Step 3 favors the "just culture" systems approach over blame.

VBC overlaps with several adjacent frameworks Step 3 may invoke as distractors or partners.

Patient safety frameworks:

Quality improvement methods:

Accreditation/recognition:

Regulatory programs not to confuse with ACO:

Patient experience:

Secondary Prevention / "Discharge Plan" — Sustaining Value in Practice

— Empanelment: each patient assigned a primary care clinician + team

— Team-based care: MA does pre-visit planning and standing orders, RN does chronic care management, pharmacist does med rec, social worker does SDOH, BH manager does CoCM

— Registry and population health dashboards: real-time gaps in care

— Risk stratification refreshed quarterly

— Standing orders for vaccines, A1c, lipids, retinal exams, mammography

— Closed-loop referrals with specialists (track that the consult happened and report came back)

— Transitions of care protocol: discharge summary to PCP within 24–48 hr, TCM visit within 7–14 d, med rec

— Post-MI: dual antiplatelet, high-intensity statin, β-blocker, ACEi/ARB, cardiac rehab, smoking cessation

— Post-stroke: antiplatelet or anticoagulation, statin, BP <130/80, A1c <7%, lifestyle

— Post-CHF admission: 4-pillar GDMT, daily weights, sodium <2 g/day, vaccinations (influenza, pneumococcal, COVID, RSV)

— Post-COPD exacerbation: inhaler technique, pulmonary rehab, vaccinations, smoking cessation, action plan

— Influenza annually, pneumococcal (PCV20 or PCV15+PPSV23), shingles (Shingrix ≥50), Tdap, COVID, RSV (≥75 or 60–74 high risk), HPV in eligible adults

— Tobacco cessation (5 A's), alcohol (SBIRT), obesity (intensive behavioral therapy covered by Medicare), exercise, diet

Step 3 management: Cardiac rehab and pulmonary rehab are underused, high-value referrals that consistently reduce readmissions and mortality — they are the "right answer" whenever the stem mentions a stable post-event patient asking "what else?"

Just as a patient gets a discharge plan, a VBC practice has a sustainability blueprint.

Core elements of a sustainable PCMH/ACO practice:

Patient-facing secondary prevention (the clinical content of VBC):

Vaccinations ACOs track:

Counseling that hits quality measures and outcomes simultaneously:

Follow-Up, Monitoring, and Patient Engagement Cadence

— Post-hospital discharge: phone within 48 hours, visit within 7 days (high-risk: CHF, COPD, AMI) or 14 days (moderate-risk); med rec at the visit

— Post-ED visit without admission: PCP contact within 3–7 days

— HTN: monthly until controlled, then q3–6 months; home BP monitoring encouraged

— DM: A1c q3 months if not at goal, q6 months if stable; annual retinal exam, foot exam, urine albumin/creatinine, lipid panel

— HFrEF: 1–2 weeks post-discharge; q1–2 weeks during titration; q3–6 months when stable on GDMT

— CKD stage 3–4: q3–6 months with BMP, urine ACR

— Anticoagulation (warfarin): INR per stability; DOAC annual CBC/CMP and renal function

— Patient portal (secure messaging, lab results, refills) — boosts adherence, satisfaction

— Shared decision-making aids (e.g., for PSA, lung cancer screening, AFib anticoagulation)

— Teach-back to confirm understanding

— Motivational interviewing for behavior change

— Home BP, home glucose, daily weights (HF), peak flow (asthma), symptom diaries

— RPM where appropriate

— % with A1c <8 and <9, % BP <140/90, % statin-eligible on statin, % up-to-date on cancer screens, readmission rate, ED visit rate, ACS-condition admission rate (ambulatory care-sensitive conditions like uncontrolled DM, CHF, COPD, asthma)

CCS pearl: After discharging a CHF patient on CCS, the order set should always include: "Schedule cardiology/PCP follow-up in 7 days," "Daily weights with sliding-scale diuretic plan," "Patient education," "Smoking cessation counseling if applicable," and "Cardiac rehab referral when stable." Missing the 7-day follow-up is the most penalized omission.

VBC explicit follow-up cadence (Step 3 loves specific intervals):

Patient engagement tools:

Self-monitoring:

Outcome metrics to track per panel:

Ethical, Legal, and Patient Safety Considerations

— Physician's primary fiduciary duty is to the individual patient, even when employed by an ACO

— A financial incentive to reduce utilization must never override medically necessary care

— Disclose financial arrangements when materially relevant

— Shared decision-making for preference-sensitive choices (PSA screening, knee replacement, AFib anticoagulation)

— Patient must be told about all reasonable options, including those outside the ACO network when clinically indicated

— CCM enrollment requires explicit patient consent (verbal documented or written), including disclosure that 20% coinsurance may apply

— ~40% of discharged patients have medication discrepancies

— Discharge summary should reach the PCP within 24–48 hours

— Medication reconciliation at every transition: admission, transfer, discharge, post-discharge visit

— Closed-loop communication to outpatient team

— Sentinel events to Joint Commission; near-misses reported through internal patient safety event systems with non-punitive "just culture"

— HACs and never events (wrong-site surgery, retained foreign object, air embolism) not reimbursed by CMS

— Risk adjustment must not penalize providers serving sicker, poorer, or minority populations

— Stratified reporting required to identify and address disparities

— Anti-Kickback Statute, Stark Law have ACO-specific waivers permitting otherwise-prohibited arrangements like shared savings distribution

— Upcoding for HCC inflation is False Claims Act territory

Board pearl (Step 3 flavor): A patient in an ACO requests an MRI you believe is not indicated. Correct action: educate the patient on evidence, document shared decision-making, and decline the test — not order it to avoid conflict, and not refuse without explanation. Patient autonomy does not include the right to harmful or non-indicated tests.

VBC introduces ethical tensions Step 3 will test directly.

Conflict between cost containment and patient advocacy:

Informed consent in VBC contexts:

Transition-of-care safety risk (most-tested patient safety scenario):

Mandatory reporting and quality:

Equity and non-discrimination:

Fraud and abuse:

High-Yield Associations and Rapid-Fire Clinical Facts

Step 3 management: When asked the single best intervention to reduce ACSC admissions in a panel, the answer is expanded primary care access (same-day appointments, after-hours care, nurse triage) plus chronic disease registries — not more specialist visits or more imaging.

MACRA (2015) repealed the SGR and created the Quality Payment Program with two tracks: MIPS and Advanced APMs.

MSSP is the largest ACO program; ACO REACH replaced Direct Contracting in 2023, emphasizing equity.

HRRP penalty conditions: AMI, CHF, pneumonia, COPD, CABG, elective THA/TKA.

HACRP penalizes the worst-performing quartile with 1% Medicare cut.

Hospital VBP: 2% withhold redistributed based on performance domains (clinical outcomes, safety, person/community engagement, efficiency/cost).

PCMH = NCQA-recognized practice model; ACO = payment/accountability structure.

HEDIS measures by NCQA; CAHPS surveys patient experience; HCAHPS for hospitals.

Triple Aim → Quadruple Aim (+ clinician wellness) → Quintuple Aim (+ equity).

Choosing Wisely: low-value services to avoid.

USPSTF Grade A/B → covered without cost-sharing under ACA.

Beers Criteria → potentially inappropriate medications in elderly.

STOPP/START → European deprescribing/prescribing tool.

LACE index → readmission risk.

HCC coding → CMS risk adjustment for capitation/benchmarks.

Star Ratings → Medicare Advantage / Part D plan quality; 5-star plans get bonuses and SEP enrollment.

PDC ≥80% → adherence quality threshold.

NTSV cesarean rate <23.6% → perinatal quality.

TCM: phone in 2 business days, visit in 7 or 14 days.

CCM: ≥2 chronic conditions, ≥20 min/month, patient consent.

AWV ≠ physical exam; includes HRA, cognitive screen, ACP.

Ambulatory care-sensitive conditions (ACSCs): DM, CHF, COPD, asthma, HTN, dehydration — admissions for these reflect outpatient care gaps.

30-day all-cause readmission is the HRRP metric — not condition-specific.

Just culture distinguishes human error (console), at-risk behavior (coach), reckless behavior (discipline).

Board Question Stem Patterns

— A 72-year-old with DM, HFrEF, CKD, and depression sees 4 specialists, has 14 medications, and 2 ED visits in 3 months. Best next step?

— Answer: Enroll in chronic care management with comprehensive med rec and care coordinator; behavioral health integration; PCP empanelment.

— CHF patient discharged. What reduces 30-day readmission?

— Answer: Phone within 48 h, visit within 7 days, med rec, GDMT optimization, daily weights, cardiac rehab.

— Patient with acute uncomplicated LBP <2 weeks wants MRI.

— Answer: Educate, decline imaging, conservative management, recheck in 4–6 weeks if no red flags.

— Frail 88-year-old has A1c 8.4%, sulfonylurea, two falls this year.

— Answer: De-intensify (stop sulfonylurea, accept higher A1c target), document goals of care.

— Clinic has low colorectal screening rates. Best intervention?

— Answer: Standing orders + registry-driven outreach with FIT mailing (proactive panel management).

— Description of retrospective shared savings with retained patient choice → MSSP ACO (not HMO, not capitation).

— Wrong medication dispensed; near-miss caught by pharmacist. Next step?

— Answer: Non-punitive event report, RCA, system fix (barcode scanning, double-check) — not disciplinary action.

— Diabetes control disparities by race in panel data.

— Answer: Stratified analysis, targeted outreach, community health worker engagement, interpreter access, SDOH screening.

— ACO bonus structure tempts undertreatment.

— Answer: Individual patient advocacy supersedes financial incentive; disclose conflicts.

Board pearl: The recurring "right answer" archetype in VBC questions is coordination, prevention, deprescribing, and the right team member at the right time — not more tests, more specialists, or more meds.

Pattern 1 — Care fragmentation:

Pattern 2 — Post-discharge transition:

Pattern 3 — Low-value test request:

Pattern 4 — Quality measure vs. individualization:

Pattern 5 — Practice redesign:

Pattern 6 — Payment model identification:

Pattern 7 — Safety event:

Pattern 8 — Equity:

Pattern 9 — Ethics:

One-Line Recap

Value-based care realigns payment so that providers — organized as ACOs, PCMHs, or bundled-payment entities — are accountable for the quality, outcomes, and total cost of a defined population, rewarding coordinated, evidence-based, preventive, and equitable care while penalizing fragmentation, low-value services, and preventable harm.

Step 3 management: When in doubt on a VBC stem, choose coordination over consultation, prevention over procedure, deprescribing over prescribing, and the primary care medical home over another specialist — that single instinct will resolve the majority of value-based care questions you encounter on exam day.

Mechanics: ACOs (esp. MSSP) earn shared savings if spending falls below a risk-adjusted benchmark while meeting quality thresholds; patients retain freedom of choice and are attributed retrospectively — distinct from HMO capitation.

Clinical levers that consistently win Step 3 VBC questions: 7-day post-discharge follow-up with TCM, medication reconciliation at every transition, GDMT optimization in HFrEF, deprescribing in the elderly via Beers/STOPP, behavioral health integration via collaborative care, SDOH screening and social work engagement, cardiac/pulmonary rehab referrals, registry-driven preventive care, and shared decision-making to decline low-value tests (Choosing Wisely).

Ethical anchor: the physician's primary duty remains to the individual patient; quality metrics and financial incentives inform but never override individualized, goals-concordant care — and frail elderly patients often warrant de-intensification even when it "misses" a quality measure.

Systems anchor: improvement comes from PDSA cycles, just culture, team-based care, and closed-loop transitions — not from blaming individuals; equity-stratified data and SDOH integration are now core, not optional, components of every modern ACO under CMS.